Mylan Pharmaceuticals, Inc.

Warning LetterClosed

United StatesFEI 1110315Issued Nov 9, 2018

View FDA's record for FEI 1110315

Source: FDA warning letter records. FDA has not published the text of this letter. To check it, open FDA's record for this establishment, listed under FEI 1110315.

Violations0

Issue DateNov 9, 2018

Product TypeDrugs

StatusClosed

Letter Details

Firm: Mylan Pharmaceuticals, Inc.
Location: United States
FEI Number: 1110315
Country: United States
Issue Date: November 09, 2018
Issuing Office: N/A
Product Type: Drugs
Status: Closed

Summary

Based on limited metadata, this FDA Warning Letter was issued to Mylan Pharmaceuticals, Inc. on November 9, 2018, regarding drug manufacturing or compliance issues. Without access to the full letter text or specific subject line, the exact nature of the violations cannot be determined from the available information. The warning falls under FDA's drug product regulatory authority, though the specific issuing office is not identified in this metadata. To understand the particular compliance concerns and required remedial actions, the complete warning letter would need to be reviewed.

Mylan Pharmaceuticals, Inc. FDA Warning Letter, November 9, 2018